Results from two phase 3 studies evaluating an investigational antihistamine-releasing contact lens (etafilcon A with ketotifen 0.019mg) showed that the treatment may benefit patients who need vision correction and also suffer from ocular allergies.
Credit: Bryan Tong Minh, GNU Free Documentation License
The post Antihistamine-Releasing Contact Lens Looks Promising in Phase 3 Trials appeared first on Healthier Environment Living Program.